SHINE trial sheds light on deadly stroke complication (IMAGE)
Caption
UVA Health's Karen Johnston, MD, the SHINE trial leader, was pleased to see the new insights into best practices for stroke care. “These data from the SHINE trial continue to inform the national stroke community about potential approaches to treating hyperglycemic stroke patients to assure better outcomes,” she said.
Credit
Dan Addison | UVA Communications
Usage Restrictions
May be used to accompany news coverage of the SHINE trial findings. All other uses require express written permission from UVA Health.
License
Original content